Nobel prize awarded for regulatory T cells discovery
The Nobel Assembly at Karolinska Institutet has decided to award the 2025 Nobel Prize in Physiology or Medicine to three scientists “for their discoveries concerning peripheral immune tolerance”.
The winners are: Mary E Brunkow, Institute for Systems Biology, Seattle, USA; Fred Ramsdell, Sonoma Biotherapeutics, San Francisco, USA; and Shimon Sakaguchi, Osaka University, Osaka, Japan.
Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi identified the immune system’s security guards, regulatory T cells (Tregs), which prevent immune cells from attacking our own body.
“Their discoveries have been decisive for our understanding of how the immune system functions and why we do not all develop serious autoimmune diseases,” said Olle Kämpe, Chair of the Nobel Committee.
The prize amount is 11 million Swedish kronor, to be shared equally between the laureates.
“Like many great scientists, Fred spent years working behind the scenes to identify the gene that caused devastating systemic autoimmune diseases in a little-known strain of mice,” commented Jeff Bluestone, Chief Executive Officer and President. “The discovery of the gene, FOXP3, changed our understanding of peripheral tolerance and led to a new field of immunotherapy.
“His seminal work—together with Alexander Rudensky, co-founder and scientific advisor to SonomaBio—have been the guiding light for our development of Treg cell therapies that we are confident will change the world of immunotherapy to treat the most difficult autoimmune diseases.
The history of Tregs
Shimon Sakaguchi made the first key discovery in 1995. At the time, many researchers were convinced that immune tolerance only developed due to potentially harmful immune cells being eliminated in the thymus, through a process called central tolerance. Sakaguchi showed that the immune system is more complex and discovered a previously unknown class of immune cells, which protect the body from autoimmune diseases.
Mary Brunkow and Fred Ramsdell made the other key discovery in 2001, when they presented the explanation for why a specific mouse strain was particularly vulnerable to autoimmune diseases. They had discovered that the mice have a mutation in a gene that they named Foxp3. They also showed that mutations in the human equivalent of this gene cause a serious autoimmune disease, IPEX.
Two years after this, Shimon Sakaguchi proved that the Foxp3 gene governs the development of the cells he identified in 1995. These cells, now known as regulatory T cells, monitor other immune cells and ensure that our immune system tolerates our own tissues.
The laureates’ discoveries launched the field of peripheral tolerance, spurring the development of medical treatments for cancer and autoimmune diseases. This may also lead to more successful transplantations. Several of these treatments are now undergoing clinical trials.
Diana Turner, Deputy Editor, DDW
